approval
saveVALPROATE SODIUM — FDA approval
community read0 votes
Sponsor: SAGENT. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 2 completionAustralasian Gastro-Intestinal Trials Group — valproate sodium (Phase II Trial Completion)Apr 30, 2026 · 160d ago
- approvalVALPROATE SODIUM — FDA approvalMar 31, 2026 · 190d ago
- approvalVALPROATE SODIUM — FDA approvalApr 4, 2024 · 916d ago
- approvalVALPROATE SODIUM — FDA approvalApr 4, 2024 · 916d ago
- approvalVALPROATE SODIUM — FDA approvalOct 11, 2016 · 3648d ago
- approvalVALPROATE SODIUM — FDA approvalDec 22, 2015 · 3942d ago
- approvalVALPROATE SODIUM — FDA approvalDec 22, 2015 · 3942d ago
- approvalVALPROATE SODIUM — FDA approvalDec 22, 2015 · 3942d ago
same company · ±60 days · 6
- approvalVALPROATE SODIUM — FDA approvalMar 31, 2026
- approvalVALPROATE SODIUM — FDA approvalMar 31, 2026
- approvalVALPROATE SODIUM — FDA approvalMar 31, 2026
- approvalVALPROATE SODIUM — FDA approvalMar 31, 2026
- approvalNOREPINEPHRINE BITARTRATE: NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (NOREPINEPHRINE BITARTRATE) — FDA approvalMar 26, 2026
- approvalGEMCITABINE HYDROCHLORIDE: GEMCITABINE HYDROCHLORIDE — FDA approvalMar 13, 2026
🐶 often sniffed alongside
top 7- tagApproval56 co-mentions · 28 sources
- drugRNS-6010 co-mentions · 10 sources
- companyFresenius Kabi USA LLC10 co-mentions · 10 sources
- tagOncology3 co-mentions · 1 sources
- tagColorectal Cancer2 co-mentions · 1 sources
- companyAustralasian Gastro-Intestinal Trials Group1 co-mentions · 1 sources
- tagGastroenterology1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that